Patents by Inventor Tze-Ting Chiou

Tze-Ting Chiou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antimicrobial peptide isolated from
    Patent number: 7670836
    Abstract: The present invention provides an antimicrobial peptide, monodoncin, which is isolated and purified from Penaeus monodon and is capable of being mass produced by molecular cloning techniques in a heterologous expression system, such as yeast. Monodoncin demonstrates a wide-range of bacteriostatic and bactericidal effects on G(?) and G(+) bacteria as well as fungicidal activities, and can be used in combination with conventional antibiotics as “cocktail therapy” to improve the therapeutic effects of the conventional antibiotics.
    Type: Grant
    Filed: May 30, 2007
    Date of Patent: March 2, 2010
    Assignee: Academia Sinica
    Inventors: Jenn-Kan Lu, Jen-Leih Wu, Tze-Ting Chiou
  • Novel antimicrobial peptide isolated from Penaeus monodon
    Publication number: 20080032385
    Abstract: The present invention provides an antimicrobial peptide, monodoncin, which is isolated and purified from Penaeus monodon and is capable of being mass produced by molecular cloning techniques in a heterologous expression system, such as yeast. Monodoncin demonstrates a wide-range of bacteriostatic and bactericidal effects on G (?) and G (+) bacteria as well as fungicidal activities, and can be used in combination with conventional antibiotics as “cocktail therapy” to improve the therapeutic effects of the conventional antibiotics.
    Type: Application
    Filed: May 30, 2007
    Publication date: February 7, 2008
    Inventors: Jenn-Kan Lu, Jen-Leih Wu, Tze-Ting Chiou
  • Novel antimicrobial peptide isolated from penaeus monodon
    Publication number: 20040235738
    Abstract: The present invention provides an antimicrobial peptide, monodoncin, which is isolated and purified from Penaeus monodon and is capable of being mass produced by molecular cloning techniques in a heterologous expression system, such as yeast. Monodoncin demonstrates a wide-range of bacteriostatic and bactericidal effects on G(−) and G(+) bacteria as well as fungicidal activities, and can be used in combination with conventional antibiotics as “cocktail therapy” to improve the therapeutic effects of the conventional antibiotics.
    Type: Application
    Filed: May 10, 2004
    Publication date: November 25, 2004
    Applicant: Academia Sinica
    Inventors: Jenn-Kan Lu, Jen-Leih Wu, Tze-Ting Chiou